Philip morris international announces appointment of two former u.s. fda officials, highlighting the company's continued commitment to smoke-free product science and regulation

Washington--(business wire)--philip morris international inc. (pmi) (nyse: pm) announced today that it has appointed two former united states food and drug administration (u.s. fda) officials to key positions to accelerate its science-based transformation. dr. badrul chowdhury is appointed pmi's chief life sciences officer, smoke-free products, succeeding jorge insuasty, who will complete his move into the recently created position of president, vectura fertin pharma. after a short transition p
PM Ratings Summary
PM Quant Ranking